Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The paracrine-responsive endothelial and ischemic tissue milieu refers to the specialized physiological microenvironment created within tissues experiencing chronic or acute oxygen deprivation. This milieu is characterized by the upregulation of hypoxia-inducible factors and the secretion of pro-angiogenic cytokines, which serve to recruit and activate cells capable of vascular repair. It is not a discrete molecular target like a receptor or enzyme, but rather a complex biological setting involving oxygen-deprived endothelial cells and a specific profile of secreted growth factors and cytokines. This milieu serves as the functional target for regenerative medicine approaches, particularly CD34+ cell therapies, which are designed to respond to local signals like SDF-1 and VEGF to promote the growth of new capillaries. By enhancing the natural angiogenic response within this environment, these therapies aim to restore blood flow in patients with conditions such as critical limb ischemia or refractory angina. The therapeutic strategy focuses on leveraging the existing paracrine signaling pathways to achieve microvascular expansion where traditional revascularization has failed.
Stimulation of microvascular expansion and angiogenesis through paracrine signaling and recruitment of progenitor cells within the ischemic environment.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine-responsive endothelial and ischemic tissue milieu.